Jennifer L Kriss1, Paula M Frew2, Marielysse Cortes3, Fauzia A Malik3, Allison T Chamberlain4, Katherine Seib3, Lisa Flowers5, Kevin A Ault6, Penelope P Howards4, Walter A Orenstein7, Saad B Omer8. 1. Emory University, Department of Epidemiology and Laney Graduate School, Atlanta, GA, United States. Electronic address: JKriss@cdc.gov. 2. Emory University, Rollins School of Public Health, Department of Behavioral Sciences and Health Education, and Division of Infectious Diseases, Department of Medicine, Atlanta, GA, United States; Emory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA, United States. 3. Emory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA, United States. 4. Emory University, Rollins School of Public Health, Department of Epidemiology, Atlanta, GA, United States. 5. Emory University, School of Medicine, Department of Gynecology and Obstetrics, Atlanta, GA, United States. 6. University of Kansas Medical Center, Department of Obstetrics and Gynecology, Kansas City, KS, United States. 7. Emory University, Emory Vaccine Center and School of Medicine, Atlanta, GA, United States. 8. Emory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA, United States; Emory University, Rollins School of Public Health, Department of Epidemiology, Atlanta, GA, United States; Emory University, Department of Pediatrics, Atlanta, GA, United States.
Abstract
BACKGROUND: Vaccination coverage with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in pregnancy or immediately postpartum has been low. Limited data exist on rigorously evaluated interventions to increase maternal vaccination, including Tdap. Tailored messaging based on the Elaboration Likelihood Model (ELM) framework has been successful in improving uptake of some public health interventions. We evaluated the effect of two ELM-based vaccine educational interventions on Tdap vaccination among pregnant African American women, a group of women who tend to have lower vaccine uptake compared with other groups. METHODS: We conducted a prospective randomized controlled trial to pilot test two interventions - an affective messaging video and a cognitive messaging iBook - among pregnant African American women recruited during routine prenatal care visits. We measured Tdap vaccination during the perinatal period (during pregnancy and immediately postpartum), reasons for non-vaccination, and intention to receive Tdap in the next pregnancy. RESULTS: Among the enrolled women (n=106), 90% completed follow-up. Tdap vaccination in the perinatal period was 18% in the control group; 50% in the iBook group (Risk Ratio [vs. control group]: 2.83; 95% CI, 1.26-6.37), and 29% in the video group (RR: 1.65; 95% CI, 0.66-4.09). From baseline to follow-up, women's reported intention to receive Tdap during the next pregnancy improved in all three groups. Among unvaccinated women, the most common reason reported for non-vaccination was lack of a recommendation for Tdap by the woman's physician. CONCLUSIONS: Education interventions that provide targeted information for pregnant women in an interactive manner may be useful to improve Tdap vaccination during the perinatal period. However, larger studies including multiple racial and ethnic groups are needed to evaluate robustness of our findings. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01740310.
RCT Entities:
BACKGROUND: Vaccination coverage with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in pregnancy or immediately postpartum has been low. Limited data exist on rigorously evaluated interventions to increase maternal vaccination, including Tdap. Tailored messaging based on the Elaboration Likelihood Model (ELM) framework has been successful in improving uptake of some public health interventions. We evaluated the effect of two ELM-based vaccine educational interventions on Tdap vaccination among pregnant African American women, a group of women who tend to have lower vaccine uptake compared with other groups. METHODS: We conducted a prospective randomized controlled trial to pilot test two interventions - an affective messaging video and a cognitive messaging iBook - among pregnant African American women recruited during routine prenatal care visits. We measured Tdap vaccination during the perinatal period (during pregnancy and immediately postpartum), reasons for non-vaccination, and intention to receive Tdap in the next pregnancy. RESULTS: Among the enrolled women (n=106), 90% completed follow-up. Tdap vaccination in the perinatal period was 18% in the control group; 50% in the iBook group (Risk Ratio [vs. control group]: 2.83; 95% CI, 1.26-6.37), and 29% in the video group (RR: 1.65; 95% CI, 0.66-4.09). From baseline to follow-up, women's reported intention to receive Tdap during the next pregnancy improved in all three groups. Among unvaccinated women, the most common reason reported for non-vaccination was lack of a recommendation for Tdap by the woman's physician. CONCLUSIONS: Education interventions that provide targeted information for pregnant women in an interactive manner may be useful to improve Tdap vaccination during the perinatal period. However, larger studies including multiple racial and ethnic groups are needed to evaluate robustness of our findings. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01740310.
Authors: Allison T Chamberlain; Katherine Seib; Kevin A Ault; Eli S Rosenberg; Paula M Frew; Marielysse Cortes; Ellen A S Whitney; Ruth L Berkelman; Walter A Orenstein; Saad B Omer Journal: Hum Vaccin Immunother Date: 2016-04-15 Impact factor: 3.452
Authors: Margaret M Cortese; Andrew L Baughman; Rongping Zhang; Pamela U Srivastava; Gregory S Wallace Journal: Pediatrics Date: 2008-03 Impact factor: 7.124
Authors: Sushena Krishnaswamy; Allen C Cheng; Euan M Wallace; Jim Buttery; Michelle L Giles Journal: Hum Vaccin Immunother Date: 2018-03-26 Impact factor: 3.452
Authors: Matthew Z Dudley; Rupali J Limaye; Daniel A Salmon; Saad B Omer; Sean T O'Leary; Mallory K Ellingson; Christine I Spina; Sarah E Brewer; Robert A Bednarczyk; Fauzia Malik; Paula M Frew; Allison T Chamberlain Journal: Public Health Rep Date: 2021-01-28 Impact factor: 2.792
Authors: Anna Larson Williams; Lois McCloskey; Magdalene Mwale; Lawrence Mwananyanda; Kenya Murray; Augusta R Herman; Donald M Thea; William B MacLeod; Christopher J Gill Journal: Vaccine Date: 2018-04-10 Impact factor: 3.641
Authors: Christopher R Wilcox; Kathryn Bottrell; Pauline Paterson; William S Schulz; Tushna Vandrevala; Heidi J Larson; Christine E Jones Journal: Vaccine Date: 2018-11-03 Impact factor: 3.641
Authors: Bahaa Abu-Raya; Kirsten Maertens; Kathryn M Edwards; Saad B Omer; Janet A Englund; Katie L Flanagan; Matthew D Snape; Gayatri Amirthalingam; Elke Leuridan; Pierre Van Damme; Vana Papaevangelou; Odile Launay; Ron Dagan; Magda Campins; Anna Franca Cavaliere; Tiziana Frusca; Sofia Guidi; Miguel O'Ryan; Ulrich Heininger; Tina Tan; Ahmed R Alsuwaidi; Marco A Safadi; Luz M Vilca; Nasamon Wanlapakorn; Shabir A Madhi; Michelle L Giles; Roman Prymula; Shamez Ladhani; Federico Martinón-Torres; Litjen Tan; Lessandra Michelin; Giovanni Scambia; Nicola Principi; Susanna Esposito Journal: Front Immunol Date: 2020-06-24 Impact factor: 7.561